Par Drugs and Chemicals Limited has announced the closure of its trading window for trading in the company's securities. This closure will be effective from Thursday, January 1, 2026. The trading window will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter and nine months ended December 31, 2025. This restriction applies to designated persons, designated employees, and their immediate relatives. All insiders of the company have been advised not to trade in the securities of Par Drugs and Chemicals Limited during this period. The company will inform the date of the Board Meeting to approve these financial results in due course.